Anthelmintic [EPC]

Anthelmintic [EPC] was reported 2907 times

Drugs of the Anthelmintic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PULMONARY ECHINOCOCCIASIS 4 0.6667
1 POTASSIUM HYDROXIDE PREPARATION POSITIVE 3 0.5000
2 MAZZOTTI REACTION 4 0.3636
3 ILEUS SPASTIC 2 0.3333
4 TREMATODE INFECTION 5 0.2500
5 FASCIOLIASIS 4 0.2000
6 STEROID DEPENDENCE 159 0.1811
7 ECHINOCOCCIASIS 13 0.1781
8 HELMINTHIC INFECTION 40 0.1646
9 FOETAL MEGACYSTIS 7 0.1591
10 SCHISTOSOMIASIS 12 0.1558
11 NEUROCYSTICERCOSIS 7 0.1556
12 CATARRH 134 0.1482
13 CONGENITAL ABSENCE OF CRANIAL VAULT 8 0.1379
14 MYOCARDITIS TOXOPLASMAL 2 0.1176
15 BIFIDOBACTERIUM INFECTION 3 0.1111
16 BALAMUTHIA INFECTION 3 0.1034
17 TAENIASIS 4 0.0952
18 ISOSPORIASIS 7 0.0897
19 FOLLICULAR DISORDER 3 0.0833
20 BURNS SECOND DEGREE 138 0.0786
21 TOXOCARIASIS 3 0.0750
22 ANORECTAL VARICES 3 0.0714
23 DISSEMINATED STRONGYLOIDIASIS 15 0.0685
24 HAEMOSIDEROSIS 18 0.0672
25 ASCARIASIS 2 0.0606
26 HEPATIC ECHINOCOCCIASIS 3 0.0600
27 STRONGYLOIDIASIS 77 0.0476
28 HYPOPNOEA 137 0.0394
29 HEPATITIS B DNA ASSAY POSITIVE 5 0.0391
30 ALCOHOL POISONING 85 0.0317
31 HERPES SIMPLEX MENINGITIS 2 0.0282
32 CESTODE INFECTION 2 0.0274
33 SUPERFICIAL INFLAMMATORY DERMATOSIS 3 0.0244
34 BRONCHIECTASIS 157 0.0233
35 MICROSPORIDIA INFECTION 8 0.0228
36 HENOCH-SCHONLEIN PURPURA NEPHRITIS 2 0.0225
37 ENTEROCOCCAL SEPSIS 18 0.0222
38 INFECTION PARASITIC 17 0.0217
39 ENTEROBIASIS 3 0.0201
40 CONGENITAL PULMONARY VALVE DISORDER 2 0.0194
41 PROLONGED PREGNANCY 3 0.0191
42 PAROSMIA 133 0.0176
43 RHINITIS 140 0.0173
44 GINGIVAL PAIN 137 0.0172
45 VANISHING BILE DUCT SYNDROME 19 0.0170
46 IRON OVERLOAD 18 0.0167
47 CARDIAC MURMUR 141 0.0163
48 CYST RUPTURE 11 0.0162
49 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 5 0.0149
50 EXOMPHALOS 8 0.0149
51 ERYTHEMA ANNULARE 4 0.0138
52 EXTRAPULMONARY TUBERCULOSIS 4 0.0136
53 MENINGOENCEPHALITIS BACTERIAL 2 0.0135
54 BILIARY FISTULA 2 0.0131
55 AORTIC VALVE THICKENING 2 0.0124
56 RED BLOOD CELL SCHISTOCYTES PRESENT 4 0.0123
57 HEPATORENAL SYNDROME 20 0.0118
58 CEREBRAL MASS EFFECT 4 0.0110
59 NEURAL TUBE DEFECT 8 0.0110
60 CONGENITAL UMBILICAL HERNIA 4 0.0107
61 IMPAIRED QUALITY OF LIFE 139 0.0097
62 MEAN PLATELET VOLUME DECREASED 8 0.0095
63 EXTRAOCULAR MUSCLE DISORDER 3 0.0093
64 CNS VENTRICULITIS 3 0.0092
65 BODY TINEA 5 0.0089
66 INTENTION TREMOR 5 0.0088
67 ALBUMIN GLOBULIN RATIO DECREASED 2 0.0086
68 HEPATITIS TOXIC 22 0.0084
69 SYNDACTYLY 7 0.0084
70 HAEMANGIOMA CONGENITAL 4 0.0084
71 BLOOD PRESSURE 2 0.0084
72 CONGENITAL SKIN DIMPLES 2 0.0083
73 PITTING OEDEMA 5 0.0082
74 BLINDNESS CORTICAL 4 0.0082
75 ABDOMINAL LYMPHADENOPATHY 7 0.0081
76 MACROCEPHALY 3 0.0077
77 CEREBRAL TOXOPLASMOSIS 7 0.0075
78 LYMPHANGITIS 6 0.0075
79 TUBULOINTERSTITIAL NEPHRITIS 137 0.0073
80 DISINHIBITION 11 0.0068
81 IMPAIRED WORK ABILITY 146 0.0068
82 KNEE DEFORMITY 10 0.0067
83 MESENTERIC PANNICULITIS 2 0.0067
84 GRUNTING 4 0.0067
85 VASCULITIS CEREBRAL 3 0.0067
86 NEUROPSYCHOLOGICAL SYMPTOMS 4 0.0066
87 SUPERINFECTION BACTERIAL 5 0.0063
88 SEPSIS NEONATAL 5 0.0062
89 ALOPECIA TOTALIS 2 0.0061
90 ABORTION THREATENED 3 0.0060
91 ACQUIRED OESOPHAGEAL WEB 2 0.0059
92 GIARDIASIS 2 0.0059
93 FREQUENT BOWEL MOVEMENTS 157 0.0058
94 MONOCYTE COUNT DECREASED 7 0.0057
95 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
96 MENINGITIS PNEUMOCOCCAL 2 0.0055
97 MENINGITIS TUBERCULOUS 3 0.0054
98 ANAL PRURITUS 11 0.0053
99 SEIZURE CLUSTER 4 0.0048
100 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 5 0.0046
101 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 3 0.0044
102 CONGENITAL HAND MALFORMATION 3 0.0044
103 CEREBRAL CYST 3 0.0044
104 SWOLLEN TONGUE 136 0.0043
105 POLYDACTYLY 5 0.0043
106 ATRIOVENTRICULAR SEPTAL DEFECT 2 0.0043
107 MALARIA 3 0.0043
108 NEONATAL ASPHYXIA 3 0.0042
109 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 7 0.0042
110 CONJUNCTIVAL HAEMORRHAGE 16 0.0042
111 ACUTE GRAFT VERSUS HOST DISEASE 19 0.0041
112 RENAL TRANSPLANT FAILURE 4 0.0040
113 EXOSTOSIS OF JAW 2 0.0040
114 NIGHTMARE 138 0.0040
115 SYSTEMIC LUPUS ERYTHEMATOSUS 140 0.0039
116 SELF INJURIOUS BEHAVIOUR 12 0.0039
117 RECTAL HAEMORRHAGE 168 0.0039
118 ENCEPHALITIS 27 0.0039
119 ACCIDENTAL OVERDOSE 139 0.0038
120 OPISTHOTONUS 3 0.0038
121 ANAL ATRESIA 2 0.0037
122 HYPEREOSINOPHILIC SYNDROME 2 0.0037
123 CONJUNCTIVAL HYPERAEMIA 13 0.0036
124 COLITIS ULCERATIVE 162 0.0036
125 DEATH NEONATAL 5 0.0036
126 LIP ULCERATION 4 0.0034
127 RENAL TUBULAR ATROPHY 3 0.0034
128 OROPHARYNGEAL CANDIDIASIS 3 0.0033
129 HAEMATOCHEZIA 180 0.0033
130 BLOOD ELECTROLYTES ABNORMAL 4 0.0032
131 XEROSIS 4 0.0032
132 SCROTAL SWELLING 3 0.0032
133 WOUND COMPLICATION 11 0.0032
134 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
135 DRUG LEVEL CHANGED 2 0.0032
136 TESTICULAR SWELLING 4 0.0032
137 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 151 0.0031
138 CROSS SENSITIVITY REACTION 3 0.0031
139 SINUS ARRHYTHMIA 4 0.0031
140 TINNITUS 141 0.0031
141 SELF-MEDICATION 12 0.0029
142 TONGUE COATED 5 0.0029
143 MEDICATION ERROR 159 0.0029
144 PHARYNGEAL ERYTHEMA 6 0.0028
145 DELAYED GRAFT FUNCTION 2 0.0028
146 TOXOPLASMOSIS 3 0.0028
147 VERTIGO 168 0.0028
148 ACARODERMATITIS 3 0.0027
149 GENITAL PAIN 4 0.0027
150 DELUSIONAL DISORDER, UNSPECIFIED TYPE 2 0.0027
151 SUPERINFECTION 4 0.0027
152 KLEBSIELLA SEPSIS 3 0.0027
153 ECZEMA 138 0.0026
154 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
155 ORAL MUCOSAL ERUPTION 4 0.0026
156 GENITAL ULCERATION 2 0.0026
157 APLASIA 5 0.0026
158 PRURITUS GENITAL 6 0.0025
159 PRETERM PREMATURE RUPTURE OF MEMBRANES 3 0.0025
160 ENCEPHALITIS VIRAL 3 0.0025
161 DEEP VEIN THROMBOSIS 160 0.0025
162 LARGE INTESTINE INFECTION 3 0.0024
163 HYPOSPADIAS 5 0.0024
164 PRODUCT COUNTERFEIT 4 0.0023
165 ADJUSTMENT DISORDER 3 0.0023
166 OCULAR ICTERUS 10 0.0023
167 OESOPHAGEAL VARICES HAEMORRHAGE 5 0.0023
168 MENINGITIS CRYPTOCOCCAL 4 0.0023
169 ANGIONEUROTIC OEDEMA 6 0.0022
170 CYTOMEGALOVIRUS VIRAEMIA 10 0.0022
171 POSTPARTUM HAEMORRHAGE 3 0.0022
172 ABDOMINAL TENDERNESS 11 0.0022
173 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
174 MENINGITIS VIRAL 3 0.0022
175 EXTENSOR PLANTAR RESPONSE 2 0.0022
176 PERIPHERAL ARTERY THROMBOSIS 3 0.0021
177 KLEBSIELLA BACTERAEMIA 2 0.0021
178 MENINGITIS BACTERIAL 3 0.0021
179 MULTIPLE CONGENITAL ABNORMALITIES 3 0.0021
180 COARCTATION OF THE AORTA 2 0.0021
181 CLEFT PALATE 4 0.0021
182 BLOOD IMMUNOGLOBULIN E INCREASED 5 0.0021
183 IDIOSYNCRATIC DRUG REACTION 2 0.0020
184 GENERALISED ANXIETY DISORDER 3 0.0020
185 STEROID DIABETES 3 0.0020
186 EOSINOPHILIA 35 0.0020
187 MIXED LIVER INJURY 6 0.0020
188 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 4 0.0019
189 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
190 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
191 HYDROCELE 2 0.0019
192 STILLBIRTH 9 0.0019
193 DYSGEUSIA 138 0.0019
194 INTENTIONAL PRODUCT USE ISSUE 161 0.0018
195 HENOCH-SCHONLEIN PURPURA 4 0.0018
196 ARTHRITIS 143 0.0018
197 KLEBSIELLA INFECTION 9 0.0018
198 GASTROINTESTINAL BACTERIAL INFECTION 2 0.0017
199 RECALLED PRODUCT 3 0.0017
200 KYPHOSIS 3 0.0017
201 FEAR OF DISEASE 3 0.0017
202 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
203 CHEILITIS 9 0.0017
204 LYMPHADENITIS 4 0.0017
205 HYDROCEPHALUS 9 0.0017
206 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
207 NARCOLEPSY 3 0.0016
208 TOXIC EPIDERMAL NECROLYSIS 24 0.0016
209 LEFT ATRIAL DILATATION 2 0.0016
210 ADVERSE DRUG REACTION 139 0.0015
211 BILIARY OBSTRUCTION 2 0.0015
212 HYPERAEMIA 3 0.0015
213 DERMATITIS BULLOUS 11 0.0015
214 EMPYEMA 3 0.0015
215 GASTROENTERITIS 22 0.0015
216 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
217 TRANSAMINASES INCREASED 33 0.0015
218 MIGRAINE 141 0.0015
219 PULMONARY EMBOLISM 140 0.0015
220 HYPOVOLAEMIC SHOCK 7 0.0015
221 ENTEROCOCCAL INFECTION 7 0.0014
222 VARICELLA ZOSTER VIRUS INFECTION 3 0.0014
223 DRUG EXPOSURE DURING PREGNANCY 49 0.0014
224 STEVENS-JOHNSON SYNDROME 32 0.0014
225 PULMONARY TUBERCULOSIS 6 0.0014
226 DERMATITIS EXFOLIATIVE 7 0.0014
227 HAEMORRHAGE IN PREGNANCY 2 0.0014
228 PALPITATIONS 159 0.0014
229 FAECES PALE 3 0.0013
230 MENINGITIS 9 0.0013
231 ENCEPHALOPATHY 33 0.0013
232 HEPATOCELLULAR DAMAGE 3 0.0013
233 DUODENITIS 4 0.0013
234 PORTAL HYPERTENSION 4 0.0013
235 NEUROLOGICAL DECOMPENSATION 3 0.0013
236 ESCHERICHIA BACTERAEMIA 3 0.0013
237 MEGACOLON 2 0.0013
238 OESOPHAGEAL CANDIDIASIS 5 0.0013
239 GASTRITIS 33 0.0013
240 INTRA-UTERINE DEATH 2 0.0012
241 SEPTIC SHOCK 54 0.0012
242 ASPERGILLUS INFECTION 8 0.0012
243 ILLUSION 2 0.0012
244 HYPERNATRAEMIA 6 0.0012
245 EOSINOPHIL COUNT INCREASED 10 0.0012
246 ABORTION SPONTANEOUS 48 0.0012
247 CEREBELLAR INFARCTION 2 0.0012
248 HEPATIC CYTOLYSIS 15 0.0012
249 HEPATOSPLENOMEGALY 3 0.0012
250 ABORTION INDUCED 11 0.0012
251 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 64 0.0012
252 MYCOBACTERIAL INFECTION 2 0.0012
253 KIDNEY FIBROSIS 2 0.0012
254 HYPERREFLEXIA 4 0.0011
255 BLOOD BILIRUBIN INCREASED 31 0.0011
256 CHOLESTASIS 22 0.0011
257 FOOD INTERACTION 2 0.0011
258 GENERALISED OEDEMA 14 0.0011
259 HEPATOCELLULAR INJURY 16 0.0011
260 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
261 BRAIN OEDEMA 14 0.0011
262 LARGE INTESTINAL ULCER 3 0.0011
263 DYSENTERY 2 0.0011
264 DEFORMITY 10 0.0011
265 YELLOW SKIN 5 0.0011
266 EXPOSURE DURING PREGNANCY 66 0.0011
267 HEPATIC NECROSIS 4 0.0011
268 BLOOD BICARBONATE DECREASED 2 0.0011
269 PRODUCT USE IN UNAPPROVED INDICATION 259 0.0010
270 PHARYNGEAL DISORDER 3 0.0010
271 POISONING 13 0.0010
272 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
273 ACUTE HEPATIC FAILURE 14 0.0010
274 BICYTOPENIA 2 0.0010
275 CONFUSIONAL STATE 164 0.0010
276 SUSPECTED COUNTERFEIT PRODUCT 4 0.0010
277 CELL DEATH 2 0.0010
278 CREPITATIONS 3 0.0010
279 METABOLIC ENCEPHALOPATHY 3 0.0010
280 BONE MARROW DISORDER 3 0.0010
281 EMPHYSEMA 10 0.0010
282 DYSAESTHESIA 3 0.0010
283 ABNORMAL FAECES 8 0.0010
284 CACHEXIA 5 0.0010
285 ABDOMINAL DISCOMFORT 163 0.0010
286 TALIPES 3 0.0010
287 UTERINE LEIOMYOMA 7 0.0010
288 TESTICULAR PAIN 3 0.0009
289 HYPERPYREXIA 4 0.0009
290 JAUNDICE 25 0.0009
291 SOMNOLENCE 187 0.0009
292 HEPATITIS ACUTE 6 0.0009
293 FOETAL EXPOSURE DURING PREGNANCY 75 0.0009
294 BACTERIAL SEPSIS 3 0.0009
295 NORMAL NEWBORN 5 0.0009
296 SKIN LACERATION 10 0.0009
297 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 165 0.0009
298 AGRANULOCYTOSIS 17 0.0009
299 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
300 CONGENITAL ANOMALY 7 0.0009
301 CYTOLYTIC HEPATITIS 3 0.0009
302 FOOT DEFORMITY 10 0.0009
303 HYPOTONIA 9 0.0009
304 LYME DISEASE 3 0.0009
305 ANXIETY DISORDER 3 0.0009
306 INTRACRANIAL PRESSURE INCREASED 5 0.0009
307 ILEUS PARALYTIC 4 0.0009
308 CALCINOSIS 2 0.0009
309 INTENTIONAL SELF-INJURY 18 0.0009
310 TONGUE ULCERATION 3 0.0009
311 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
312 PNEUMOTHORAX 14 0.0009
313 PREMATURE DELIVERY 14 0.0009
314 NEUTROPHIL COUNT INCREASED 9 0.0009
315 PATHOGEN RESISTANCE 8 0.0009
316 EYE MOVEMENT DISORDER 6 0.0009
317 BRAIN OPERATION 2 0.0009
318 BRONCHOPNEUMONIA 3 0.0009
319 HELICOBACTER INFECTION 9 0.0009
320 CEREBROVASCULAR ACCIDENT 148 0.0009
321 NEPHROGENIC ANAEMIA 4 0.0009
322 HYPERTRANSAMINASAEMIA 6 0.0009
323 AUTOIMMUNE HEPATITIS 6 0.0009
324 PYREXIA 293 0.0008
325 DIVERTICULUM 6 0.0008
326 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0008
327 ODYNOPHAGIA 5 0.0008
328 DIABETES INSIPIDUS 2 0.0008
329 SKIN PLAQUE 7 0.0008
330 DRUG-INDUCED LIVER INJURY 26 0.0008
331 COVID-19 144 0.0008
332 EYE OEDEMA 2 0.0008
333 PARADOXICAL DRUG REACTION 3 0.0008
334 SPRUE-LIKE ENTEROPATHY 4 0.0008
335 DENTAL OPERATION 2 0.0008
336 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5 0.0008
337 ACUTE PSYCHOSIS 2 0.0008
338 HEPATOTOXICITY 18 0.0008
339 TENDON INJURY 3 0.0008
340 CYST 10 0.0008
341 MALNUTRITION 9 0.0008
342 THROAT CLEARING 3 0.0008
343 PROTEIN TOTAL DECREASED 3 0.0008
344 CONDITION AGGRAVATED 241 0.0008
345 TOXIC ENCEPHALOPATHY 4 0.0008
346 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
347 ABDOMINAL INFECTION 2 0.0008
348 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
349 PRODUCT PRESCRIBING ISSUE 17 0.0008
350 DISSEMINATED TUBERCULOSIS 2 0.0008
351 MENOPAUSE 2 0.0008
352 EYELID OEDEMA 9 0.0008
353 APLASTIC ANAEMIA 4 0.0008
354 PNEUMONIA FUNGAL 3 0.0008
355 OESOPHAGEAL PAIN 3 0.0008
356 LUNG OPACITY 2 0.0008
357 BACTERAEMIA 9 0.0008
358 LOW BIRTH WEIGHT BABY 6 0.0008
359 JOINT RANGE OF MOTION DECREASED 10 0.0007
360 FUNGAL SKIN INFECTION 3 0.0007
361 PANCYTOPENIA 41 0.0007
362 ANAPHYLACTOID REACTION 3 0.0007
363 ABASIA 18 0.0007
364 CYTOMEGALOVIRUS INFECTION 12 0.0007
365 LARGE INTESTINE POLYP 5 0.0007
366 CHROMATURIA 16 0.0007
367 PREMATURE LABOUR 4 0.0007
368 GENERALISED ERYTHEMA 4 0.0007
369 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
370 SKIN HYPERPIGMENTATION 6 0.0007
371 DEPRESSION 158 0.0007
372 HEPATIC LESION 3 0.0007
373 HYPERTONIC BLADDER 2 0.0007
374 ORAL CANDIDIASIS 9 0.0007
375 HYPERTRIGLYCERIDAEMIA 4 0.0007
376 ABDOMINAL ABSCESS 3 0.0007
377 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
378 HEPATITIS FULMINANT 2 0.0007
379 DYSTONIA 13 0.0007
380 THERAPY NON-RESPONDER 30 0.0007
381 PRODUCT TASTE ABNORMAL 9 0.0007
382 PAPILLOEDEMA 3 0.0007
383 ACNE CYSTIC 2 0.0007
384 HIV INFECTION 2 0.0007
385 WEIGHT DECREASED 184 0.0007
386 GRAND MAL CONVULSION 6 0.0006
387 SEDATION 17 0.0006
388 SPINAL FRACTURE 13 0.0006
389 GASTRITIS EROSIVE 3 0.0006
390 KIDNEY TRANSPLANT REJECTION 3 0.0006
391 CUSHINGOID 2 0.0006
392 LYMPHOCYTE COUNT DECREASED 11 0.0006
393 PROCTALGIA 4 0.0006
394 MULTIPLE DRUG OVERDOSE INTENTIONAL 2 0.0006
395 RASH VESICULAR 3 0.0006
396 INCOHERENT 4 0.0006
397 HYPOVENTILATION 2 0.0006
398 PLATELET COUNT INCREASED 8 0.0006
399 INCORRECT DOSAGE ADMINISTERED 3 0.0006
400 ASPHYXIA 5 0.0006
401 COMA 29 0.0006
402 DEAFNESS NEUROSENSORY 2 0.0006
403 ESCHERICHIA INFECTION 5 0.0006
404 LISTLESS 2 0.0006
405 INABILITY TO AFFORD MEDICATION 6 0.0006
406 DRUG LEVEL INCREASED 10 0.0006
407 EXPOSURE DURING BREAST FEEDING 2 0.0006
408 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 3 0.0006
409 PRURITUS GENERALISED 13 0.0006
410 CONVULSION 34 0.0006
411 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
412 HEPATIC CYST 2 0.0006
413 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
414 ABNORMAL LOSS OF WEIGHT 4 0.0006
415 HEPATITIS 15 0.0006
416 SKIN LESION 16 0.0006
417 HEPATIC FIBROSIS 2 0.0006
418 MYOPATHY 5 0.0006
419 SKIN NECROSIS 3 0.0006
420 EYE DISCHARGE 6 0.0006
421 TONSILLITIS 3 0.0006
422 AORTIC STENOSIS 2 0.0006
423 CYANOSIS 9 0.0006
424 ACUTE RESPIRATORY FAILURE 11 0.0006
425 LIVER INJURY 14 0.0006
426 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
427 PAPULE 4 0.0006
428 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
429 NYSTAGMUS 3 0.0006
430 GLOSSITIS 2 0.0006
431 NEUTROPENIC SEPSIS 4 0.0006
432 ANAL FISSURE 3 0.0006
433 FRUSTRATION 2 0.0006
434 PAIN IN EXTREMITY 161 0.0005
435 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
436 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
437 UROSEPSIS 5 0.0005
438 SKIN ULCER 14 0.0005
439 HYPOPHOSPHATAEMIA 4 0.0005
440 HAEMATOTOXICITY 5 0.0005
441 DERMATITIS 11 0.0005
442 NEUROLOGICAL SYMPTOM 3 0.0005
443 ENTEROCOLITIS 3 0.0005
444 METABOLIC DISORDER 3 0.0005
445 ELECTROLYTE IMBALANCE 6 0.0005
446 OEDEMA 28 0.0005
447 APNOEA 4 0.0005
448 NEUROTOXICITY 9 0.0005
449 HEPATOMEGALY 5 0.0005
450 NAIL DISCOLOURATION 2 0.0005
451 RESPIRATORY DISTRESS 14 0.0005
452 CHOLECYSTITIS 6 0.0005
453 PROTHROMBIN TIME PROLONGED 3 0.0005
454 ABSCESS 8 0.0005
455 ENURESIS 2 0.0005
456 SHOCK HAEMORRHAGIC 4 0.0005
457 PIGMENTATION DISORDER 3 0.0005
458 DISEASE RECURRENCE 23 0.0005
459 OLIGURIA 3 0.0005
460 HYPERBILIRUBINAEMIA 5 0.0005
461 RESPIRATORY FAILURE 35 0.0005
462 HYPOKALAEMIA 22 0.0005
463 BUNDLE BRANCH BLOCK LEFT 2 0.0005
464 RENAL FAILURE ACUTE 20 0.0005
465 ANAPHYLACTIC REACTION 26 0.0005
466 HEPATIC PAIN 2 0.0005
467 RASH 201 0.0005
468 SKIN SWELLING 4 0.0005
469 RESPIRATORY TRACT INFECTION 12 0.0005
470 SOMNAMBULISM 3 0.0005
471 ASPIRATION 5 0.0005
472 ABDOMINAL PAIN 106 0.0005
473 HAEMATOCRIT DECREASED 9 0.0005
474 IMMUNOSUPPRESSION 4 0.0005
475 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
476 RESPIRATORY RATE INCREASED 4 0.0005
477 SKIN MASS 3 0.0004
478 CHOLECYSTITIS CHRONIC 3 0.0004
479 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
480 HEADACHE 279 0.0004
481 BONE MARROW FAILURE 9 0.0004
482 LEUKOPENIA 22 0.0004
483 ECCHYMOSIS 3 0.0004
484 DISEASE COMPLICATION 2 0.0004
485 IMMUNE THROMBOCYTOPENIA 2 0.0004
486 ISCHAEMIA 2 0.0004
487 GASTRIC HAEMORRHAGE 5 0.0004
488 LOCALISED OEDEMA 2 0.0004
489 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
490 LIVER DISORDER 19 0.0004
491 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
492 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
493 SEPSIS 47 0.0004
494 ATAXIA 5 0.0004
495 HYPERLIPIDAEMIA 5 0.0004
496 FAECAL INCONTINENCE 2 0.0004
497 OFF LABEL USE 364 0.0004
498 GUILLAIN-BARRE SYNDROME 2 0.0004
499 ORAL DISORDER 3 0.0004
500 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
501 METABOLIC ACIDOSIS 13 0.0004
502 PSYCHOTIC DISORDER 12 0.0004
503 PARANOIA 7 0.0004
504 BREATH SOUNDS ABNORMAL 2 0.0004
505 ILEUS 5 0.0004
506 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
507 PREGNANCY 8 0.0004
508 PREMATURE BABY 12 0.0004
509 SEIZURE 46 0.0004
510 APHASIA 12 0.0004
511 ECONOMIC PROBLEM 6 0.0004
512 HYPERTHERMIA 3 0.0004
513 VOMITING 184 0.0004
514 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
515 ANOREXIA 5 0.0004
516 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
517 LEUKOCYTOSIS 7 0.0004
518 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
519 HYPOALBUMINAEMIA 3 0.0004
520 FOETAL DEATH 2 0.0004
521 C-REACTIVE PROTEIN INCREASED 14 0.0004
522 PETECHIAE 4 0.0004
523 FOLLICULITIS 4 0.0004
524 MOUTH ULCERATION 8 0.0004
525 BLOOD LACTIC ACID INCREASED 2 0.0004
526 BLOOD ALBUMIN DECREASED 3 0.0004
527 SUDDEN DEATH 4 0.0004
528 CONJUNCTIVITIS 7 0.0004
529 EAR INFECTION 10 0.0004
530 HEPATIC FUNCTION ABNORMAL 14 0.0004
531 NEUTROPENIA 51 0.0004
532 HALLUCINATION 28 0.0004
533 BRUXISM 2 0.0004
534 MUSCLE DISORDER 3 0.0004
535 FAECES DISCOLOURED 8 0.0004
536 OESOPHAGITIS 4 0.0004
537 FAECALOMA 2 0.0004
538 INTESTINAL ISCHAEMIA 2 0.0004
539 COAGULOPATHY 6 0.0004
540 MENTAL STATUS CHANGES 10 0.0004
541 ATRIAL SEPTAL DEFECT 3 0.0004
542 CHOLECYSTITIS ACUTE 2 0.0004
543 DEHYDRATION 47 0.0004
544 CIRCULATORY COLLAPSE 6 0.0004
545 FACIAL PARALYSIS 3 0.0004
546 GRANULOCYTOPENIA 2 0.0004
547 TREATMENT FAILURE 29 0.0003
548 CARDIAC VALVE DISEASE 2 0.0003
549 PSEUDOMONAS INFECTION 3 0.0003
550 RED BLOOD CELL COUNT DECREASED 10 0.0003
551 RASH GENERALISED 9 0.0003
552 MULTI-ORGAN FAILURE 6 0.0003
553 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
554 VASCULITIS 4 0.0003
555 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
556 DRUG INEFFECTIVE 449 0.0003
557 LUNG INFILTRATION 3 0.0003
558 PAIN 206 0.0003
559 ASTHENIA 126 0.0003
560 HAEMOLYTIC ANAEMIA 3 0.0003
561 RENAL IMPAIRMENT 28 0.0003
562 HEPATITIS B 2 0.0003
563 INGUINAL HERNIA 2 0.0003
564 DERMATITIS ACNEIFORM 2 0.0003
565 SMALL INTESTINAL OBSTRUCTION 4 0.0003
566 CHOLANGITIS 2 0.0003
567 ERYTHEMA MULTIFORME 3 0.0003
568 DERMATITIS ALLERGIC 4 0.0003
569 OCULAR HYPERAEMIA 15 0.0003
570 HAEMATEMESIS 8 0.0003
571 DRUG INTERACTION 50 0.0003
572 FOREIGN BODY SENSATION IN EYES 2 0.0003
573 ACUTE KIDNEY INJURY 48 0.0003
574 ORAL PAIN 7 0.0003
575 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
576 ATELECTASIS 3 0.0003
577 ANAPHYLACTIC SHOCK 8 0.0003
578 LIVER FUNCTION TEST ABNORMAL 9 0.0003
579 SKIN EXFOLIATION 26 0.0003
580 HERPES SIMPLEX 2 0.0003
581 HAEMORRHOIDS 6 0.0003
582 CHOKING 6 0.0003
583 BRADYPHRENIA 2 0.0003
584 OSTEONECROSIS 10 0.0003
585 HYPOGAMMAGLOBULINAEMIA 2 0.0003
586 SHOCK 7 0.0003
587 BEDRIDDEN 4 0.0003
588 IMMUNE SYSTEM DISORDER 4 0.0003
589 PULMONARY CONGESTION 4 0.0003
590 ABNORMAL BEHAVIOUR 12 0.0003
591 PHOTOSENSITIVITY REACTION 5 0.0003
592 CARDIAC FAILURE ACUTE 2 0.0003
593 TOXIC SKIN ERUPTION 3 0.0003
594 DECREASED APPETITE 69 0.0003
595 ABDOMINAL DISTENSION 31 0.0003
596 DRUG LEVEL DECREASED 3 0.0003
597 NEUTROPHIL COUNT DECREASED 12 0.0003
598 EPILEPSY 9 0.0003
599 MOTOR DYSFUNCTION 3 0.0003
600 BODY TEMPERATURE INCREASED 6 0.0003
601 TACHYCARDIA 26 0.0003
602 JOINT EFFUSION 2 0.0003
603 LYMPHOEDEMA 2 0.0003
604 MENTAL IMPAIRMENT 7 0.0003
605 ANAEMIA 55 0.0003
606 NERVOUS SYSTEM DISORDER 9 0.0003
607 DELIRIUM 10 0.0003
608 FATIGUE 223 0.0003
609 GENERAL PHYSICAL HEALTH DETERIORATION 33 0.0003
610 COLD SWEAT 5 0.0003
611 BLINDNESS UNILATERAL 4 0.0003
612 RENAL PAIN 3 0.0003
613 BRONCHOSPASM 4 0.0003
614 GALLBLADDER DISORDER 5 0.0003
615 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2 0.0003
616 BLOOD CHOLESTEROL INCREASED 13 0.0003
617 TOXICITY TO VARIOUS AGENTS 47 0.0003
618 DISCOMFORT 17 0.0003
619 DISORIENTATION 11 0.0003
620 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
621 ABDOMINAL PAIN UPPER 57 0.0003
622 LOSS OF CONSCIOUSNESS 35 0.0003
623 TOOTH FRACTURE 3 0.0003
624 UNRESPONSIVE TO STIMULI 7 0.0003
625 VISUAL ACUITY REDUCED 9 0.0003
626 CEREBRAL DISORDER 2 0.0003
627 RASH MACULO-PAPULAR 6 0.0003
628 DIPLOPIA 7 0.0003
629 RESPIRATORY DISORDER 8 0.0003
630 MUCOSAL INFLAMMATION 7 0.0003
631 NEPHROPATHY TOXIC 3 0.0003
632 BLISTER 15 0.0003
633 FISTULA 3 0.0003
634 EYE PAIN 15 0.0003
635 STATUS EPILEPTICUS 3 0.0003
636 MYOCARDIAL ISCHAEMIA 3 0.0003
637 CARDIO-RESPIRATORY ARREST 11 0.0003
638 INTENTIONAL PRODUCT MISUSE 23 0.0003
639 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
640 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
641 THROMBOCYTOPENIA 29 0.0003
642 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
643 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
644 PALLOR 7 0.0003
645 SPLENOMEGALY 3 0.0003
646 BLOOD IRON DECREASED 3 0.0003
647 HAEMOPTYSIS 7 0.0003
648 ATRIAL FLUTTER 2 0.0003
649 HYPOTHYROIDISM 8 0.0003
650 ALOPECIA 49 0.0002
651 VISION BLURRED 34 0.0002
652 DYSKINESIA 10 0.0002
653 RESTLESSNESS 9 0.0002
654 DECUBITUS ULCER 2 0.0002
655 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
656 CARDIOMEGALY 3 0.0002
657 HYPERAESTHESIA 2 0.0002
658 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
659 MENSTRUAL DISORDER 2 0.0002
660 ASTHMA 27 0.0002
661 ASCITES 7 0.0002
662 ABDOMINAL PAIN LOWER 6 0.0002
663 FACE OEDEMA 4 0.0002
664 PRURITUS 91 0.0002
665 URINARY INCONTINENCE 7 0.0002
666 INTENTIONAL OVERDOSE 15 0.0002
667 SCAR 4 0.0002
668 HEPATIC FAILURE 7 0.0002
669 HYPERSENSITIVITY 43 0.0002
670 MUSCLE STRAIN 2 0.0002
671 MUSCULAR WEAKNESS 26 0.0002
672 NAIL DISORDER 2 0.0002
673 EMOTIONAL DISORDER 7 0.0002
674 DIZZINESS 113 0.0002
675 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
676 LETHARGY 13 0.0002
677 EYE HAEMORRHAGE 3 0.0002
678 PAIN OF SKIN 6 0.0002
679 PNEUMONITIS 6 0.0002
680 GINGIVAL BLEEDING 3 0.0002
681 END STAGE RENAL DISEASE 4 0.0002
682 PERIPHERAL COLDNESS 3 0.0002
683 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
684 URTICARIA 36 0.0002
685 CARPAL TUNNEL SYNDROME 3 0.0002
686 DIARRHOEA HAEMORRHAGIC 2 0.0002
687 BLOOD TEST ABNORMAL 3 0.0002
688 OEDEMA PERIPHERAL 26 0.0002
689 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
690 HEPATIC CIRRHOSIS 4 0.0002
691 PHOTOPHOBIA 4 0.0002
692 SINUS TACHYCARDIA 3 0.0002
693 ARRHYTHMIA 10 0.0002
694 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
695 SYNCOPE 21 0.0002
696 SKIN DISORDER 7 0.0002
697 HEPATIC ENZYME INCREASED 14 0.0002
698 CEREBRAL INFARCTION 5 0.0002
699 COELIAC DISEASE 2 0.0002
700 ANGIOEDEMA 9 0.0002
701 DISEASE PROGRESSION 24 0.0002
702 PULMONARY MASS 3 0.0002
703 DIARRHOEA 130 0.0002
704 TREATMENT NONCOMPLIANCE 11 0.0002
705 GASTROINTESTINAL DISORDER 18 0.0002
706 PNEUMONIA ASPIRATION 5 0.0002
707 MYALGIA 34 0.0002
708 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
709 LYMPHADENOPATHY 7 0.0002
710 BALANCE DISORDER 17 0.0002
711 SKIN DISCOLOURATION 9 0.0002
712 DEVICE RELATED INFECTION 3 0.0002
713 HAEMOGLOBIN DECREASED 20 0.0002
714 DRUG RESISTANCE 5 0.0002
715 INFLAMMATION 10 0.0002
716 TOOTH LOSS 4 0.0002
717 THERAPY PARTIAL RESPONDER 3 0.0002
718 BRAIN FOG 3 0.0002
719 ANHEDONIA 5 0.0002
720 HALLUCINATION, VISUAL 4 0.0002
721 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
722 INCONTINENCE 2 0.0002
723 RESPIRATORY TRACT CONGESTION 3 0.0002
724 EYE SWELLING 7 0.0002
725 CHILLS 22 0.0002
726 SENSORY DISTURBANCE 3 0.0002
727 IRRITABLE BOWEL SYNDROME 4 0.0002
728 SUICIDAL IDEATION 17 0.0002
729 MUSCLE TIGHTNESS 3 0.0002
730 COLITIS 7 0.0002
731 SWELLING FACE 12 0.0002
732 BACK INJURY 2 0.0002
733 GAIT DISTURBANCE 35 0.0002
734 GASTROINTESTINAL PAIN 2 0.0002
735 MELAENA 4 0.0002
736 DRUG ABUSE 15 0.0002
737 BLOOD UREA INCREASED 3 0.0002
738 WOUND 5 0.0002
739 RASH PAPULAR 4 0.0002
740 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
741 NAUSEA 140 0.0002
742 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
743 MYOCARDITIS 2 0.0002
744 HYPERSOMNIA 5 0.0002
745 NEOPLASM 2 0.0002
746 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
747 MUSCLE TWITCHING 4 0.0002
748 LOCAL SWELLING 3 0.0002
749 SPEECH DISORDER 9 0.0002
750 SWELLING 16 0.0002
751 DRUG ERUPTION 3 0.0002
752 MYOCLONUS 2 0.0002
753 PRODUCTIVE COUGH 8 0.0002
754 BURSITIS 2 0.0002
755 AGITATION 12 0.0002
756 HYPERHIDROSIS 21 0.0002
757 DYSURIA 6 0.0002
758 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
759 HEPATIC STEATOSIS 3 0.0002
760 HAIR COLOUR CHANGES 2 0.0002
761 AGGRESSION 8 0.0002
762 PLATELET COUNT DECREASED 17 0.0002
763 BLOOD SODIUM DECREASED 3 0.0002
764 HYPOCALCAEMIA 3 0.0002
765 BLOOD URINE PRESENT 3 0.0002
766 MUSCLE ATROPHY 2 0.0002
767 GASTRIC ULCER 3 0.0002
768 PROTEINURIA 3 0.0002
769 PNEUMONIA 51 0.0002
770 PULMONARY OEDEMA 7 0.0002
771 ERUCTATION 3 0.0002
772 PRESCRIBED OVERDOSE 3 0.0002
773 HIATUS HERNIA 2 0.0002
774 EAR PAIN 3 0.0002
775 STAPHYLOCOCCAL INFECTION 5 0.0002
776 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
777 ADVERSE REACTION 2 0.0002
778 GAIT INABILITY 5 0.0001
779 FEAR 4 0.0001
780 THERAPEUTIC RESPONSE DECREASED 9 0.0001
781 ANGER 5 0.0001
782 BLINDNESS 6 0.0001
783 DRUG TOXICITY 2 0.0001
784 IMPAIRED GASTRIC EMPTYING 2 0.0001
785 RASH ERYTHEMATOUS 7 0.0001
786 OSTEOPOROSIS 6 0.0001
787 PERITONITIS 3 0.0001
788 CHRONIC KIDNEY DISEASE 11 0.0001
789 TREMOR 24 0.0001
790 RHABDOMYOLYSIS 6 0.0001
791 FEELING COLD 4 0.0001
792 HYPOMAGNESAEMIA 2 0.0001
793 COORDINATION ABNORMAL 2 0.0001
794 APHONIA 2 0.0001
795 LUNG DISORDER 7 0.0001
796 HYPONATRAEMIA 8 0.0001
797 TARDIVE DYSKINESIA 4 0.0001
798 LYMPHOPENIA 2 0.0001
799 EATING DISORDER 3 0.0001
800 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
801 ANGINA PECTORIS 4 0.0001
802 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
803 MYELOSUPPRESSION 5 0.0001
804 HYPERTHYROIDISM 2 0.0001
805 DRUG EFFECT INCOMPLETE 5 0.0001
806 HYPERGLYCAEMIA 5 0.0001
807 PANIC ATTACK 5 0.0001
808 COLON CANCER 2 0.0001
809 IMMUNODEFICIENCY 2 0.0001
810 ANXIETY 38 0.0001
811 PANCREATITIS ACUTE 3 0.0001
812 HEART RATE IRREGULAR 3 0.0001
813 HOT FLUSH 10 0.0001
814 MALAISE 58 0.0001
815 UNEVALUABLE EVENT 10 0.0001
816 PRODUCT AVAILABILITY ISSUE 3 0.0001
817 ADVERSE EVENT 12 0.0001
818 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
819 OVERDOSE 28 0.0001
820 RASH PRURITIC 7 0.0001
821 DELUSION 2 0.0001
822 INJURY 9 0.0001
823 PRODUCT USE ISSUE 24 0.0001
824 MOVEMENT DISORDER 4 0.0001
825 OXYGEN SATURATION DECREASED 7 0.0001
826 DRUG INTOLERANCE 12 0.0001
827 CONSTIPATION 27 0.0001
828 FLATULENCE 7 0.0001
829 BLOOD CREATININE INCREASED 8 0.0001
830 CHOLELITHIASIS 4 0.0001
831 MULTIPLE FRACTURES 2 0.0001
832 MANIA 2 0.0001
833 VISUAL IMPAIRMENT 15 0.0001
834 VIRAL INFECTION 4 0.0001
835 FUNGAL INFECTION 4 0.0001
836 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
837 HEMIPARESIS 2 0.0001
838 HYPOPHAGIA 3 0.0001
839 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
840 MENTAL DISORDER 5 0.0001
841 HAEMORRHAGE 12 0.0001
842 RASH MACULAR 4 0.0001
843 BURNING SENSATION 8 0.0001
844 HYPOXIA 4 0.0001
845 PANCREATITIS 6 0.0001
846 CHEST PAIN 21 0.0001
847 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
848 RENAL FAILURE 15 0.0001
849 BREAST CANCER FEMALE 3 0.0001
850 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
851 CARDIAC ARREST 9 0.0001
852 NEPHROLITHIASIS 5 0.0001
853 ABNORMAL DREAMS 3 0.0001
854 BRONCHITIS 8 0.0001
855 ARTHROPATHY 6 0.0001
856 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
857 AMNESIA 7 0.0001
858 RENAL DISORDER 5 0.0001
859 BACTERIAL INFECTION 2 0.0001
860 DYSARTHRIA 4 0.0001
861 INTESTINAL OBSTRUCTION 4 0.0001
862 RHEUMATOID ARTHRITIS 12 0.0001
863 FRACTURE 2 0.0001
864 FEBRILE NEUTROPENIA 7 0.0001
865 DYSPHAGIA 10 0.0001
866 BLOOD GLUCOSE DECREASED 5 0.0001
867 DRUG PRESCRIBING ERROR 2 0.0001
868 ERYTHEMA 21 0.0001
869 DISABILITY 2 0.0001
870 HYPOAESTHESIA 15 0.0001
871 HYPOTENSION 20 0.0001
872 BACK PAIN 23 0.0001
873 SUICIDE ATTEMPT 6 0.0001
874 INFLUENZA 11 0.0001
875 FEEDING DISORDER 2 0.0001
876 DRY MOUTH 8 0.0001
877 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
878 OROPHARYNGEAL PAIN 9 0.0001
879 ILLNESS 10 0.0001
880 DYSPNOEA 53 0.0001
881 NIGHT SWEATS 3 0.0001
882 DEATH 80 0.0001
883 MUSCLE SPASMS 17 0.0001
884 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
885 DIABETES MELLITUS 7 0.0001
886 DYSPEPSIA 9 0.0001
887 EYE DISORDER 3 0.0001
888 HEART RATE INCREASED 9 0.0001
889 URINARY RETENTION 3 0.0001
890 NECK PAIN 5 0.0001
891 GLOSSODYNIA 2 0.0001
892 EYE PRURITUS 3 0.0001
893 PARAESTHESIA 14 0.0001
894 ARTHRALGIA 37 0.0001
895 SKIN IRRITATION 4 0.0001
896 CARDIAC FAILURE 7 0.0001
897 HERPES ZOSTER 5 0.0001
898 INSOMNIA 23 0.0001
899 COGNITIVE DISORDER 4 0.0001
900 HYPERKALAEMIA 3 0.0001
901 INFLUENZA LIKE ILLNESS 7 0.0001
902 HYPERTENSION 18 0.0001
903 WHEEZING 5 0.0001
904 NEUROPATHY PERIPHERAL 8 0.0001
905 SKIN BURNING SENSATION 6 0.0001
906 FEELING ABNORMAL 20 0.0001
907 IRRITABILITY 5 0.0001
908 CRYING 3 0.0001
909 HYPOGLYCAEMIA 4 0.0001
910 FIBROMYALGIA 2 0.0001
911 COUGH 23 0.0001
912 FEELING HOT 5 0.0001
913 EXTRAPYRAMIDAL DISORDER 2 0.0001
914 MEMORY IMPAIRMENT 11 0.0001
915 DYSPNOEA EXERTIONAL 3 0.0001
916 CELLULITIS 4 0.0001
917 CHEST DISCOMFORT 8 0.0001
918 RHINORRHOEA 5 0.0001
919 DEAFNESS 2 0.0001
920 APPLICATION SITE ERYTHEMA 2 0.0001
921 NASOPHARYNGITIS 14 0.0001
922 DISTURBANCE IN ATTENTION 4 0.0001
923 LIMB INJURY 2 0.0001
924 DIVERTICULITIS 2 0.0001
925 BLOOD PRESSURE INCREASED 11 0.0001
926 POLLAKIURIA 3 0.0001
927 INTENTIONAL DOSE OMISSION 2 0.0001
928 VAGINAL HAEMORRHAGE 3 0.0001
929 INFECTION 10 0.0001
930 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
931 BLOOD POTASSIUM DECREASED 2 0.0001
932 LACRIMATION INCREASED 2 0.0001
933 ACNE 5 0.0001
934 DRUG ADMINISTRATION ERROR 2 0.0001
935 BONE DENSITY DECREASED 2 0.0001
936 HEAD INJURY 2 0.0001
937 PSORIASIS 8 0.0001
938 BLOOD PRESSURE DECREASED 4 0.0001
939 THERAPY CESSATION 3 0.0001
940 PERIPHERAL SWELLING 9 0.0001
941 HAEMATURIA 2 0.0001
942 GASTRIC DISORDER 2 0.0001
943 WEIGHT INCREASED 13 0.0001
944 NEOPLASM PROGRESSION 2 0.0001
945 MUSCULOSKELETAL STIFFNESS 5 0.0001
946 DEPRESSED MOOD 3 0.0001
947 CEREBRAL HAEMORRHAGE 2 0.0001
948 UNDERDOSE 4 0.0001
949 FALL 18 0.0001
950 EPISTAXIS 4 0.0001
951 EYE IRRITATION 3 0.0001
952 PRODUCT SUBSTITUTION ISSUE 3 0.0001
953 MYOCARDIAL INFARCTION 9 0.0001
954 DYSPHONIA 3 0.0001
955 NASAL CONGESTION 3 0.0001
956 EMOTIONAL DISTRESS 6 0.0000
957 LUNG NEOPLASM MALIGNANT 2 0.0000
958 INCORRECT DOSE ADMINISTERED 11 0.0000
959 HOSPITALISATION 7 0.0000
960 PRODUCT DOSE OMISSION ISSUE 13 0.0000
961 PRODUCT QUALITY ISSUE 6 0.0000
962 SLEEP DISORDER 3 0.0000
963 MULTIPLE SCLEROSIS 2 0.0000
964 MOBILITY DECREASED 3 0.0000
965 CONTUSION 4 0.0000
966 JOINT SWELLING 5 0.0000
967 ATRIAL FIBRILLATION 4 0.0000
968 URINARY TRACT INFECTION 7 0.0000
969 DRY EYE 2 0.0000
970 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
971 SINUSITIS 4 0.0000
972 NO ADVERSE EVENT 7 0.0000
973 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
974 MUSCULOSKELETAL PAIN 2 0.0000
975 BRADYCARDIA 2 0.0000
976 DRY SKIN 5 0.0000
977 CARDIAC FAILURE CONGESTIVE 3 0.0000
978 THROMBOSIS 3 0.0000
979 BLOOD GLUCOSE INCREASED 7 0.0000
980 DRUG EFFECT DECREASED 2 0.0000
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
982 CARDIAC DISORDER 3 0.0000
983 DRUG DEPENDENCE 5 0.0000
984 DRUG DOSE OMISSION 5 0.0000
985 INFUSION RELATED REACTION 2 0.0000
986 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
987 INJECTION SITE REACTION 2 0.0000
988 DEVICE MALFUNCTION 2 0.0000
989 COMPLETED SUICIDE 2 0.0000
990 DRUG WITHDRAWAL SYNDROME 2 0.0000
991 BREAST CANCER 2 0.0000
992 FLUSHING 2 0.0000
993 INJECTION SITE PAIN 5 0.0000